Pantorilla, Jake Steven T.
HRN: 15-45-57 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/28/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/28/2022
12/30/2022
IVT
500mg
Q8H
S/P LTCS
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes